Clinical Trials
29 trialsPembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Alliance for Clinical Trials in Oncology
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA
City of Hope Medical Center
ОС26
Military Medical Clinical Center of the Southern Region, Ukraine
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
M.D. Anderson Cancer Center
Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic
Baptist Health South Florida
Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
RAINBO
Leiden University Medical Center
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
Roswell Park Cancer Institute
Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer
City of Hope Medical Center
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Mayo Clinic
SPARE-1st
Eye & ENT Hospital of Fudan University
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
NRG Oncology
Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial
NRG Oncology
LAP100
NRG Oncology
MPN Childhood Registry
University of Erlangen-Nürnberg Medical School
SAVED LUNG
Centre hospitalier de l'Université de Montréal (CHUM)
The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center
The First Affiliated Hospital of Soochow University
XAI-EGC
The First Affiliated Hospital of Soochow University
EECRTKI
University of Pisa
DMU-CH
Fenerbahce University
DIVINE
Mayo Clinic
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients
University of Michigan Rogel Cancer Center
RESCUE
North Eastern German Society of Gynaecological Oncology
Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)
Dana-Farber Cancer Institute
Communication Issues in Patient and Provider Discussions of Immunotherapy
Emory University
EURACAN
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma
First Affiliated Hospital of Wenzhou Medical University
GIVEN
Guangdong Provincial People's Hospital